Filing metadata

Accession number
0000902664-23-002155
Form type
Form 3
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Mar 08, 2023
Reporting period
Jan 01, 2023
Description
Initial ownership

Explore SEC Filings Hub